Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
1.405 USD | -0.35% | -81.25% | -87.03% |
Apr. 17 | Truist Adjusts Marinus Pharmaceuticals' PT to $10 From $25, Keeps Buy Rating | MT |
Apr. 16 | Baird Downgrades Marinus Pharmaceuticals to Neutral, Price Target at $2 | MT |
- Stock Market
- Equities
- MRNS Stock
- News Marinus Pharmaceuticals, Inc.